Figura 3. Given these results apparently it is very unlikely that endogenous glucocorticoids contribute to bone loss during acute inflammation; the latter possibly It could be the case under non-inflammatory physiological conditions. Another aspect of the invention relates to the use of the rBHT protein or cells that express rBHT to produce a food or dietary supplement containing galacto-oligosaccharides GOS. Identification of Galectin-3 as a factor in pre-mRNA splicing. Examples of suitable expression vectors for use in mammalian host cells include pcD A3.
nest...